After Hours
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities.
Stocks Info
As a NASDAQ listed company, LENZ falls under the Healthcare sector while operating within the Biotechnology industry segment. The current market capitalization of LENZ Therapeutics Inc is $551.33M. A total of 0.6 million shares were traded on the day, compared to an average of 1.17M shares.
In the most recent transaction, Olsson Shawn sold 10,000 shares of LENZ for 26.10 per share on Nov 17 ’25. After the transaction, the Chief Commercial Officer now owns 4,733 company shares. In a previous transaction on Nov 17 ’25, SHAWN OLSSON bought 40,000 shares at 25.60 per share.
Among the insiders who bought shares, MCCOLLUM JAMES W acquired of 10,500 shares on Nov 07 ’25 at a per-share price of $22.79. This resulted in the Director holding 10,500 shares of LENZ after the transaction. In another insider transaction, Chevallard Daniel R. bought 2,198 shares at $22.76 per share on Nov 07 ’25. Company shares held by the Chief Financial Officer now total 5,386.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, LENZ has a high of $50.40 and a low of $15.70.
As of this writing, LENZ has an earnings estimate of -$0.96 per share for the current quarter. EPS was calculated based on a consensus of 5.0 estimates, with a high estimate of -$0.8 per share and a lower estimate of -$1.04. The company reported an EPS of -$0.46 in the last quarter
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. LENZ’s latest balance sheet shows that the firm has $18.31M in Cash & Short Term Investments as of fiscal 2021. There were $0.00 in debt and $1.25M in liabilities at the time. Its Book Value Per Share was $6.78, while its Total Shareholder’s Equity was -$14.21M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for LENZ is Buy with a score of 4.75.
